We study the mitochondrial, nuclear and lysosomal dynamics that viruses hijack during infection, and translate that biology into vaccines and antivirals for infectious diseases with unmet medical needs.
The lab combines molecular virology, cell biology and innate immunology to understand how RNA and DNA viruses remodel host organelles — and uses those insights to build better vaccines and antivirals.
Mitochondrial fission and mitophagy, nuclear and lysosomal remodeling — how hepatitis viruses, coronaviruses and flaviviruses reshape organelles to establish persistent infection.
Dissecting virus–host interactions that tune RIG-I-like receptor signaling, interferon induction and inflammation, using animal models of emerging viral disease.
Antigen design, platform development and preclinical evaluation of vaccines and antiviral candidates against emerging and re-emerging viruses.